Welcome on the webpage of the invitation-only launch of a Europe-wide Hospital Engagement Programme on the enhanced use of Electronic Health Records for Clinical Research. This conference will be attended by decision-powered delegates from 100 hospitals that are Centres of Excellence across Europe, and by over 20 senior representatives from Pharma.
The event will present and demonstrate the results of the IMI project Electronic Health Records for Clinical Research (EHR4CR), which has developed a platform to accelerate and optimise services (e.g. recruitment) for clinical trials by connecting to the EHR system at each participating hospital securely and with full privacy protection.Hospitals will be offered higher efficiency in participating in clinical trials, a potential increase of their research income, as well as an enhancement of their reputation as centres of research. The EHR4CR services have already been piloted at eleven European hospitals, and are about to be scaled up to a commercially supported service.
For Pharma this implies reducing the time taken to conduct a clinical trial by many months and speeding up the delivery of innovative medicines to healthcare.
Dr Ruxandra Draghia-Akli is Director of the Health Directorate at the Research DG of the European Commission. Previously, Ruxandra Draghia-Akli served as Vice President of Research at VGX Pharmaceuticals...
Paul Timmers is Director of the Sustainable & Secure Society Directorate in the European Commission Communications Networks, Content and Technologies Directorate General (DG CONNECT). Previously he headed...
Michel Goldman is the Executive Director of IMI, he builds and promotes networks of innovation, in close collaboration with all stakeholders involved in pharmaceutical R&D. He supports the launch and successful...
The EHR4CR project is making great progress with its ambitious targets for the development and deployment of an innovative technical platform...
The EHR4CR project is one of several projects making up the Innovative Medicines Initiative (to date one of the largest public-private...
Bron Kisler, VP CDISC Strategic Initiatives recently had the opportunity to give the keynote presentation at the IMI EHR4CR Annual Stakeholder...
Dr. Mats Sundgren
Dr. Andreas Schmidt
F Hoffmann-La Roche Ltd
Prof. Dr. Dipak Kalra
Prof. Dr. Georges De Moor
The EHR4CR project is partially funded by the IMI Programme.
The(IMI) is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.